Kim Janda - Director at Sorrento Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SRNE on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kim Janda since 9/17/2023

Holdings reported by Kim Janda for Sorrento Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3K $2.41K $0.80 Dec 27, 2021 Direct
Non-qualified stock option 0 Dec 27, 2021 Direct Common Stock

Transactions reported by Kim Janda for Sorrento Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.